Proud to fund research initiatives to help kids with cancer.

Personalised targeted therapy for adolescent and young adult medulloblastoma patients
Personalised targeted therapy for adolescent and young adult medulloblastoma patients
Institute: University of Sydney
Recipient: Dr Elizabeth Hovey
Funding: $287,332 July 2019 to June 2022
Exploiting CDK4/6 inhibition to treat medulloblastoma
Exploiting CDK4/6 inhibition to treat medulloblastoma
Institute: University of Queensland
Recipient: Professor Brandon Wainwright
Funding: $196,207 July 2019 to June 2022
Targeting the NAD pathway as a new therapeutic strategy for high-risk leukaemia in children
Targeting the NAD pathway as a new therapeutic strategy for high-risk leukaemia in children
Institute: University of NSW
Recipient: Dr Michelle Henderson
Funding: $138,179 July 2019 to June 2022
Targeting Polo-like kinase 1 as a novel therapeutic opportunity for diffuse intrinsic pontine glioma
Targeting Polo-like kinase 1 as a novel therapeutic opportunity for diffuse intrinsic pontine glioma
Institute: Sydney Children's Hospital
Recipient: Associate Professor David Ziegler
Funding: $278,282 July 2019 to June 2022
Understanding the genetic basis of chemotherapy-induced cardiomyopathy
Understanding the genetic basis of chemotherapy-induced cardiomyopathy
Institute: The Murdoch Children’s Research Institute
Recipient: Dr Rachel Conyers
Funding: $590,877 July 2018 to June 2022
IntReALL-HR
IntReALL-HR
Institute: ANZCHOG
Recipient: Associate Professor Tamas Revesz
Funding: $416,422 July 2018 to June 2022
MicroRNA drugs for the treatment of neuroblastoma
MicroRNA drugs for the treatment of neuroblastoma
Institute: Garvan Institute of Medical Research
Recipient: Associate Professor Alexander Swarbrick
Funding: $308,270 July 2018 to June 2021
The NORTH Trial
The NORTH Trial
Institute: ANZCHOG
Recipient: Dr Paul Wood
Funding: $61,420 July 2018 to June 2021
New state-wide Children’s and Adolescent/Young Adult Cancer Clinical Trials Unit
New state-wide Children’s and Adolescent/Young Adult Cancer Clinical Trials Unit
Institute: Royal Hobart Hospital
Recipient: Associate Professor John Heath
Funding: $280,000 July 2017 to June 2022
Personalised Medicine: Zero Childhood Cancer
Personalised Medicine: Zero Childhood Cancer
Institute: Children’s Cancer Institute
Recipient: Professor Michelle Haber
Funding: $1,167,250 July 2014 to June 2021
New therapies for incurable paediatric brain tumours
New therapies for incurable paediatric brain tumours
Institute: The Institute of Molecular Bioscience
Recipient: Professor Brandon Wainwright
Funding: $224,936 July 2018 to June 2020
Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia
Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia
Institute: Telethon Kids Institute
Recipient: Dr Rishi Kotecha
Funding: $180,000 February 2018 to January 2020
Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic
Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic
Institute: Children’s Cancer Institute
Recipient: Professor Richard Lock
Funding: $103,571 July 2017 to June 2020
Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma
Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma
Institute: UNSW Australia
Recipient: Dr Daniel Carter
Funding: $296,428 July 2016 to June 2020
Synthetic retinoid therapy for diffuse intrinsic pontine glioma
Synthetic retinoid therapy for diffuse intrinsic pontine glioma
Institute: Children’s Cancer Institute
Recipient: Associate Professor David Ziegler
Funding: $200,000 July 2016 to June 2020
Science is the solution for kids with cancer
The only way to improve outcomes for children diagnosed with cancer is through advances in medical research. Every day and every donation takes us closer to a cure.
Select your donation details
Please enter the amount you would like to donate

The Kids' Cancer Project is an ACNC Registered Charity 
ABN 13 061 138 181 | CFN 10581